PDF《康泰生物（300601）》

2016 2017 2018E 2019E 2020E 少数股东权益 0.00 0.00 0.00 0.00 0.00 成长能力 股本 369.00 421.14 421.14 421.14 421.14 营业收入 21.91% 110.38% 63.17% 46.83% 38.24% 资本公积 197.28 431.37 431.37 431.37 431.37 营业利润 23.89% 182.64% 77.66% 62.41% 42.32% 留存收益 366.00 790.13 1,170.25 1,725.68 2,559.30 归属于母公司净利润 37.24% 149.04% 95.70% 51.44% 41.50% 其他 (197.28) (571.63) (431.37) (431.37) (431.37) 获利能力 股东权益合计 735.00 1,071.01 1,591.39 2,146.82 2,980.45 毛利率 78.57% 88.26% 90.01% 90.86% 91.38% 负债和股东权益总 计1,600.90 2,210.71 2,753.37 3,519.83 4,255.92 净利率 15.62% 18.49% 22.18% 22.87% 23.41% ROE 11.73% 20.0........